Elite Surgical Profile
Key Indicators
- Authorised Capital ₹ 3.05 Cr
as on 30-07-2024
- Paid Up Capital ₹ 3.03 Cr
as on 30-07-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -44.65%
(FY 2023)
- Profit -2653.72%
(FY 2023)
- Ebitda -2258.00%
(FY 2023)
- Net Worth -38.61%
(FY 2023)
- Total Assets -2.08%
(FY 2023)
About Elite Surgical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.05 Cr and a paid-up capital of Rs 3.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Patwardhan, Apoorva Patwardhan, and Saloni Kulkarni serve as directors at the Company.
- CIN/LLPIN
U33119PN2016PTC166316
- Company No.
166316
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Elite Surgical?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Patwardhan  | Director | 19-Aug-2020 | Current |
| Apoorva Patwardhan | Director | 05-Sep-2016 | Current |
| Saloni Kulkarni | Director | 05-Sep-2016 | Current |
Financial Performance of Elite Surgical.
Elite Surgical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.65% decrease. The company also saw a substantial fall in profitability, with a 2653.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elite Surgical?
In 2023, Elite Surgical had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dhanashree Hospital LlpActive 1 year 8 monthsRajeev Patwardhan and Apoorva Patwardhan are mutual person
- Arp Ventures Private LimitedActive 5 years 10 months
Rajeev Patwardhan and Apoorva Patwardhan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Elite Surgical?
Elite Surgical has a workforce of 13 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elite Surgical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elite Surgical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
